Detalhe da pesquisa
1.
Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice.
Hum Mol Genet
; 30(16): 1469-1483, 2021 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902111
2.
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.
Brain
; 145(3): 1001-1017, 2022 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285474
3.
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Ann Neurol
; 75(3): 351-62, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24243558
4.
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.
Proc Natl Acad Sci U S A
; 109(24): 9611-6, 2012 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22647602
5.
Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
Hum Mol Genet
; 21(4): 874-89, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22076440
6.
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Brain
; 136(Pt 8): 2369-78, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23884809
7.
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.
NPJ Parkinsons Dis
; 9(1): 135, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726343
8.
Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.
Glob Health Action
; 15(1): 2062175, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35730550
9.
Pathogenic lysosomal depletion in Parkinson's disease.
J Neurosci
; 30(37): 12535-44, 2010 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20844148
10.
Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins.
Ann Neurol
; 68(2): 184-92, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20695011
11.
The kinase domain of mitochondrial PINK1 faces the cytoplasm.
Proc Natl Acad Sci U S A
; 105(33): 12022-7, 2008 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18687899
12.
Mitochondrial alterations in Parkinson's disease: new clues.
J Neurochem
; 107(2): 317-28, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18680555
13.
Molecular pathways of programmed cell death in experimental Parkinson's disease.
Parkinsonism Relat Disord
; 14 Suppl 2: S176-9, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18595766
14.
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.
Front Neurosci
; 12: 342, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875626
15.
Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease.
Cell Death Dis
; 9(11): 1122, 2018 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405116
16.
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.
J Clin Invest
; 112(6): 892-901, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12975474
17.
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
J Neurosci
; 25(28): 6594-600, 2005 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16014720
18.
Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.
Front Mol Neurosci
; 9: 128, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27917109
19.
The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
Neuroscientist
; 22(3): 266-77, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25761946
20.
Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat.
J Neurosci
; 22(19): 8711-9, 2002 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12351746